These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 23578341)

  • 1. Asymmetric dimethylarginine predicts decline of glucose tolerance in men with stable coronary artery disease: a 4.5-year follow-up study.
    Surdacki A; Kruszelnicka O; Rakowski T; Jaźwińska-Kozuba A; Dubiel JS
    Cardiovasc Diabetol; 2013; 12():64. PubMed ID: 23578341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential associations of angiographic extent and severity of coronary artery disease with asymmetric dimethylarginine but not insulin resistance in non-diabetic men with stable angina: a cross-sectional study.
    Kruszelnicka O; Surdacki A; Golay A
    Cardiovasc Diabetol; 2013 Oct; 12():145. PubMed ID: 24103320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated concentrations of asymmetric dimethylarginine are associated with deterioration of glucose tolerance in women with previous gestational diabetes mellitus.
    Mittermayer F; Kautzky-Willer A; Winzer C; Krzyzanowska K; Prikoszovich T; Demehri S; Wagner O; Wolzt M
    J Intern Med; 2007 Apr; 261(4):392-8. PubMed ID: 17391114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A correlational study between serum asymmetric dimethylarginine level and impaired glucose tolerance patients associated with obesity.
    Huang S; Xu Y; Peng WF; Cheng J; Li HH; Shen LS; Xia LL
    J Cell Physiol; 2019 Jul; 234(7):10640-10645. PubMed ID: 30536533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prediction roles of asymmetric dimethyl-arginine, adiponectin and apelin for macroangiopathy in patients with impaired glucose regulation.
    Huang S; Zou D; Peng W; Jiang X; Shao K; Xia L; Tang Y
    Ann Endocrinol (Paris); 2016 Dec; 77(6):633-640. PubMed ID: 27641081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study.
    Siegerink B; Maas R; Vossen CY; Schwedhelm E; Koenig W; Böger R; Rothenbacher D; Brenner H; Breitling LP
    Clin Res Cardiol; 2013 Mar; 102(3):193-202. PubMed ID: 23073705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADMA is a correlate of insulin resistance in early-stage diabetes independent of hs-CRP and body adiposity.
    Nakhjavani M; Karimi-Jafari H; Esteghamati A; Khalilzadeh O; Asgarani F; Ghadiri-Anari A
    Ann Endocrinol (Paris); 2010 Sep; 71(4):303-8. PubMed ID: 20434720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pioglitazone decreases asymmetric dimethylarginine levels in patients with impaired glucose tolerance or type 2 diabetes.
    Tahara N; Yamagishi S; Mizoguchi M; Tahara A; Imaizumi T
    Rejuvenation Res; 2013 Oct; 16(5):344-51. PubMed ID: 23777507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of ADMA, endothelial progenitor cells and traditional cardiovascular risk factors on pulse wave velocity among prediabetic individuals.
    Protopsaltis I; Foussas S; Angelidi A; Gritzapis A; Sergentanis TΝ; Matsagos S; Tzirogiannis K; Panoutsopoulos GI; Dimitriadis G; Raptis S; Melidonis A
    Cardiovasc Diabetol; 2012 Nov; 11():141. PubMed ID: 23153108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel predictor of restenosis and adverse cardiac events: asymmetric dimethylarginine.
    Ari H; Ari S; Erdoğan E; Tiryakioğlu O; Ustündağ Y; Huysal K; Koca V; Bozat T
    Heart Vessels; 2010 Jan; 25(1):19-26. PubMed ID: 20091394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of dimethylarginine dimethylaminohydrolase 1 gene polymorphism with type 2 diabetes: a cohort study.
    Lu TM; Lin SJ; Lin MW; Hsu CP; Chung MY
    Cardiovasc Diabetol; 2011 Feb; 10():16. PubMed ID: 21303562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of hyperinsulinaemia, insulin resistance and β-cell dysfunction with incident diabetes and pre-diabetes: the Tehran Lipid and Glucose Study.
    Derakhshan A; Tohidi M; Arshi B; Khalili D; Azizi F; Hadaegh F
    Diabet Med; 2015 Jan; 32(1):24-32. PubMed ID: 25131451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymmetric Dimethylarginine Predicts Long-Term Outcome in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Vögeli A; Ottiger M; Meier MA; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
    Lung; 2017 Dec; 195(6):717-727. PubMed ID: 28852826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria.
    Zobel EH; von Scholten BJ; Reinhard H; Persson F; Teerlink T; Hansen TW; Parving HH; Jacobsen PK; Rossing P
    Cardiovasc Diabetol; 2017 Jul; 16(1):88. PubMed ID: 28697799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community.
    Böger RH; Sullivan LM; Schwedhelm E; Wang TJ; Maas R; Benjamin EJ; Schulze F; Xanthakis V; Benndorf RA; Vasan RS
    Circulation; 2009 Mar; 119(12):1592-600. PubMed ID: 19289633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia.
    Vögeli A; Ottiger M; Meier MA; Steuer C; Bernasconi L; Kulkarni P; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
    Respir Res; 2017 Jan; 18(1):25. PubMed ID: 28114935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Levels of Protein-Bound Methylglyoxal-Derived Hydroimidazolone-1 are Independently Correlated with Asymmetric Dimethylarginine.
    Tahara N; Kojima R; Yoshida R; Bekki M; Sugiyama Y; Tahara A; Maeda S; Honda A; Igata S; Nakamura T; Sun J; Matsui T; Fukumoto Y; Matsui T; Yamagishi SI
    Rejuvenation Res; 2019 Oct; 22(5):431-438. PubMed ID: 30661488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between Body Mass Index, Asymmetric Dimethylarginine and Risk of Cardiovascular Events and Mortality in Norwegian Patients with Suspected Stable Angina Pectoris.
    Borgeraas H; Hertel JK; Svingen GF; Pedersen ER; Seifert R; Nygård O; Hjelmesæth J
    PLoS One; 2016; 11(3):e0152029. PubMed ID: 27003294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition.
    Wang Z; Tang WH; Cho L; Brennan DM; Hazen SL
    Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1383-91. PubMed ID: 19542023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal glucose tolerance in young male patients with nonalcoholic fatty liver disease.
    Yun JW; Cho YK; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI
    Liver Int; 2009 Apr; 29(4):525-9. PubMed ID: 19323780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.